Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · IEX Real-Time Price · USD
-0.32 (-1.62%)
Apr 23, 2024, 2:37 PM EDT - Market open

Kyverna Therapeutics Statistics

Total Valuation

KYTX has a market cap or net worth of $828.46 million. The enterprise value is $771.02 million.

Market Cap 828.46M
Enterprise Value 771.02M

Important Dates

The next estimated earnings date is Sunday, May 12, 2024, before market open.

Earnings Date May 12, 2024
Ex-Dividend Date n/a

Share Statistics

KYTX has 43.12 million shares outstanding.

Shares Outstanding 43.12M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.06

Current Ratio 3.06
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -321.81

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -85.00%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$628,813
Employee Count 96
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (1Y) n/a
52-Week Price Change n/a
50-Day Moving Average 25.78
200-Day Moving Average n/a
Relative Strength Index (RSI) 32.39
Average Volume (30 Days) 389,928

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -62.41M
Pretax Income -60.37M
Net Income -60.37M
EBITDA -56.75M
EBIT -60.18M
Earnings Per Share (EPS) -$89.61
Full Income Statement

Balance Sheet

The company has $58.11 million in cash and $9.08 million in debt, giving a net cash position of $49.03 million or $1.14 per share.

Cash & Cash Equivalents 58.11M
Total Debt 9.08M
Net Cash 49.03M
Net Cash Per Share $1.14
Equity / Book Value -131.40M
Book Value Per Share -3.05
Working Capital 40.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$52.41 million and capital expenditures -$621,000, giving a free cash flow of -$53.03 million.

Operating Cash Flow -52.41M
Capital Expenditures -621,000
Free Cash Flow -53.03M
FCF Per Share -$78.73
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

KYTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -7.36%
FCF Yield -6.47%

Analyst Forecast

The average price target for KYTX is $39.50, which is 105.89% higher than the current price. The consensus rating is "Buy".

Price Target $39.50
Price Target Difference 105.89%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Altman Z-Score n/a
Piotroski F-Score 1